Johnson & Johnson (JNJ) Notes Payables (2009 - 2026)

Johnson & Johnson has disclosed Notes Payables across 18 years of filings, most recently posting $17.5 billion for Q1 2026.

• Notes Payables for Q1 2026 came in at $17.5 billion, up 25.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.5 billion (up 25.64% YoY), and the FY2025 annual result was $8.5 billion, up 41.99% from the prior year.
• Notes Payables came in at $17.5 billion for Q1 2026 at Johnson & Johnson, up from $8.5 billion in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $18.0 billion in Q2 2023 to a low of $3.5 billion in Q4 2023.
• The 5-year median for Notes Payables is $7.4 billion (2025), against an average of $8.5 billion.
• Peak annual rise in Notes Payables reached 318.41% in 2023, while the deepest fall reached 72.95% in 2023.
• Johnson & Johnson's Notes Payables stood at $4.4 billion in 2022, then retreated by 21.99% to $3.5 billion in 2023, then surged by 73.37% to $6.0 billion in 2024, then jumped by 41.99% to $8.5 billion in 2025, then jumped by 105.53% to $17.5 billion in 2026.
• The last three Notes Payables figures came in at $17.5 billion (Q1 2026), $8.5 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.